Senior Editor (Hotels) NeuTigers, an Artificial Intelligence company spun out of Princeton University, said it launched CovidDeep, a clinically validated solution that can triage those needing further testing for SARS-CoV-2/COVID-19 using physiological sensors data derived from wearable devices. The CovidDeep app is 90%+ accurate in predicting whether a person is virus-free or virus-positive, and is twice as effective as current triage tools, such as temperature checks and questionnaires. Early in the pandemic, NeuTigers realized its StarDeep™ Smart Healthcare Platform, which delivers AI-powered solutions to augment healthcare professionals’ productivity, could be used in the fight against COVID-19. CovidDeep was developed through rigorous clinical research and validation trials beginning at San Matteo Hospital in Pavia, Italy, during the acute phase of the COVID-19 pandemic in April 2020, with further expanded prospective field studies in hospitals in France and the United States to explore its robustness.